Vector BioPharma logo

Vector BioPharma

ID: 13190880

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

2

Funding Rounds

$60.0m

Money raised

Overview

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding series

Funding Series Analysis

The company Vector BioPharma has raised a total of $60m in funding over 2 rounds.

Key Insights:

  • Vector BioPharma Series A round, August 10, 2022: $30m
  • Vector BioPharma August 2022 Series A Funding Round: $30m

Industries

Vector BioPharma is active in the following industries: